Topic: Advanced Cell Technology Inc.
The first-ever trial using human embryonic stem cells to treat paralysis has been halted due to high costs, and the company will focus instead on new cancer treatments, Geron said Tuesday.The California-based biotech firm, which had bypassed federal funding to get its ...
LONDON (Reuters) - A decision by one of the biggest names in stem cell research to throw in the towel will not stop other pioneering work that could yet produce cures for blindness and help mend broken hearts.Scientists were shocked by U.S. ...
LONDON (Reuters) - British drug regulators have granted approval to Advanced Cell Technology to conduct the first trial in Europe of human embryonic stem cells, testing the cells in people with a progressive form of blindness, the firm said on Thursday.Massachusetts-based ACT ...
A US biotech company said Thursday it will soon begin the first-ever European trials using human embryonic stem cells in an experimental treatment for people with a form of juvenile blindness.The Massachusetts-based Advanced Cell Technology said the trials will involve 12 patients ...
A US biotech company said Thursday it will soon begin the first-ever European trials using human embryonic stem cells in an experimental treatment for people with a form of juvenile blindness.The Massachusetts-based Advanced Cell Technology said the trials will involve 12 patients ...
Cures for paralysis, blindness and diabetes could all be in reach with embryonic stem cell research, but the pursuit of medical progress is being choked by the US rush to secure patents, experts say.Scientists are busily filing for legal patents that give ...
Two US companies this year broke new ground by winning regulatory approval to start the first experiments using embryonic stem cells on humans suffering from spinal cord injury and blindness.The potent but hotly debated cells can transform into nearly any cell in ...
Two US companies this year broke new ground by winning regulatory approval to start the first experiments using embryonic stem cells on humans suffering from spinal cord injury and blindness.The potent but hotly debated cells can transform into nearly any cell in ...
WASHINGTON (Reuters) - Christopher Goodrich of Portland, Oregon, can't wait to stick a needle in his eye.Goodrich hopes to be one of the first patients enrolled in clinical trial that just got a go-ahead from the U.S. Food and Drug Administration, only ...
WASHINGTON (Reuters) - The U.S. Food and Drug Administration has approved the second human trial of human embryonic stem cells -- this one testing cells in people with a progressive form of blindness, the company said on Monday.Massachusetts-based Advanced Cell Technology said ...